| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |